![2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, hydrochloride (1:1)](https://static.cymitquimica.com/products/AN/img/AG001L8M.png "Cliccare per ingrandire")
2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, hydrochloride (1:1)
CAS: 148849-67-6
Rif. AN-AG001L8M
| 1g | Fuori produzione | ||
| 5g | Fuori produzione | ||
| 100mg | Fuori produzione | ||
| 250mg | Fuori produzione |
Informazioni sul prodotto
Nome:
2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, hydrochloride (1:1)
Sinonimi:
- [u'7,8-dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one', u'Corlanor', u'ivabradine', u'S 16257', u'S 16257 2', u'S 16257-2', u'S 162572', u'S 16260 2', u'S 16260-2', u'S 162602', u'S-16257', u'S-16257-2', u'S-16260-2', u'S16257', u'S162572', u'S162602', u'Ivabradine hydrochloride', u'148849-67-6', u'Ivabradine HCl', u'Procoralan', u'Ivabradine (hydrochloride)', u'UNII-TP19837BZK', u'Corlanor', u'Corlentor', u'TP19837BZK', u'CHEBI:85969', u'(S)-3-(3-(((3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one hydrochloride', u'NCGC00181343-01', u'S-16257', u'(S)-3-(3-(((3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one hydrochloride', u'3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one Hydrochloride', u'Ivabradine HCl (Procoralan)', u's16257', u'Coralan', u'IvabradineHCl', u'S-16260-2', u'Corlentor (TN)', u'Corlanor (TN)', u'AK-46411', u'AC1MIILZ', u'Ivabrandine hydrochloride', u'ivabradine-hcl-procoralan', u'ivabradine monohydrochloride', u'DSSTox_CID_26913', u'DSSTox_RID_82011', u'DSSTox_GSID_46913', u'SCHEMBL23470', u'C27H37ClN2O5', u'MLS006010110', u'Ivabradine hydrochloride (JAN)', u'CHEMBL2145077', u'DTXSID2046913', u'Ivabradine hydrochloride [USAN]', u'CTK8E8827', u'HY-B0162A', u'AMG-998', u'AOB4729', u'HLUKNZUABFFNQS-ZMBIFBSDSA-N', u'3-[3-[[(8S)-3,4-Dimethoxy-8-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride', u'BCP05218', u'KS-000004OB', u'Tox21_112802', u'AC-543', u'AN-618', u'CI0043', u'MFCD00929899', u's2086', u'AKOS015849582', u'AKOS016002249', u'API0000615', u'BCP9000798', u'CS-1994', u'GS-3584', u'RL01883', u'RTC-070922', u'SB12485', u'(7,8-Dimethoxy 3-(3-(((1S)-(4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one hydrochloride', u'BC226246', u'LS-28024', u'SC-20079', u'SMR004701246', u'Ivabradine hydrochloride, >=98% (HPLC)', u'AB0011288', u'AX8135490', u'TC-070922', u'AM20090729', u'B1360', u'CAS-148849-67-6', u'FT-0659345', u'I0847', u'ST24036090', u'D08095', u'974I008', u'J-008523', u'J-521616', u'2H-3-Benzazepin-2-one, 3-(3-((((7S)-3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride', u'2H-3-Benzazepin-2-one, 3-(3-(((3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride, (S)-', u'3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one hydrochloride', u'3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methyl-amino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride']
- 2H-3-Benzazepin-2-one, 3-[3-[[(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride, (S)-
- 2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride
- 3-[3-[[(8S)-3,4-Dimethoxy-8-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride
- 3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one Hydrochloride
- 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride
- Bicyclo[4.2.0]octane, 2H-3-benzazepin-2-one deriv.
- Corlanor
- Corlentor
- Ivabradine HCl
- Vedi altri sinonimi
- Procoralan
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
505.0461
Formula:
C27H37ClN2O5
Purezza:
99%
Colore/Forma:
Solid
InChI:
InChI=1S/C27H36N2O5.ClH/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30;/h12-14,16,21H,6-11,15,17H2,1-5H3;1H/t21-;/m1./s1
InChI key:
HLUKNZUABFFNQS-ZMBIFBSDSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
